If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.
Danial Arkwell, PhD
Advertisement
Articles by Danial Arkwell, PhD
Advertisement
Latest Updated Articles
How Efficient Cold Chain Logistics Can Change the Lives of Rare Disease PatientsPublished: April 10th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
2
Trade & Channel Strategies 2025: Inside Pharma’s Turning Point
3
Pharma Pulse: Amgen's Uplizna Secures CD19 Approval for Myasthenia Gravis, as Asthma Biologic Switches Highlight Efficacy Expectations Gap
4
Working with the Middle
5
